These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22507911)

  • 1. Exposure to potentially toxic hydrocarbons and halocarbons released from the dialyzer and tubing set during hemodialysis.
    Lee HJ; Meinardi S; Pahl MV; Vaziri ND; Blake DR
    Am J Kidney Dis; 2012 Oct; 60(4):609-16. PubMed ID: 22507911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hemodialysis and diet on the exhaled breath methanol concentration in patients with ESRD.
    Lee HJ; Pahl MV; Vaziri ND; Blake DR
    J Ren Nutr; 2012 May; 22(3):357-64. PubMed ID: 22100775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breath analysis as promising indicator of hemodialysis efficiency.
    Grabowska-Polanowska B; Miarka P; Skowron M; Chmiel G; Pietrzycka A; Śliwka I
    Clin Exp Nephrol; 2019 Feb; 23(2):251-257. PubMed ID: 30121801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of hemodialysis on exhaled volatile organic compounds in end-stage renal disease: a pilot study.
    Assady S; Marom O; Hemli M; Ionescu R; Jeries R; Tisch U; Abassi Z; Haick H
    Nanomedicine (Lond); 2014 May; 9(7):1035-45. PubMed ID: 24066923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volatile breath biomarkers for patient monitoring during haemodialysis.
    Goerl T; Kischkel S; Sawacki A; Fuchs P; Miekisch W; Schubert JK
    J Breath Res; 2013 Mar; 7(1):017116. PubMed ID: 23446309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased hydrogen peroxide in the exhaled breath of uraemic patients unaffected by haemodialysis.
    Rysz J; Kasielski M; Apanasiewicz J; Król M; Woźnicki A; Luciak M; Nowak D
    Nephrol Dial Transplant; 2004 Jan; 19(1):158-63. PubMed ID: 14671051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].
    Olszewska M
    Ann Acad Med Stetin; 2004; 50(1):41-52. PubMed ID: 16871743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
    Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
    Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of two-hour daily hemodialysis and sham dialysis on breath isoprene exhalation.
    Capodicasa E; Brunori F; De Medio GE; Pelli MA; Vecchi L; Buoncristiani U
    Int J Artif Organs; 2007 Jul; 30(7):583-8. PubMed ID: 17674334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is good about PD + HD combined therapy.
    Yamashita AC; Tomisawa N
    Hemodial Int; 2011 Oct; 15 Suppl 1():S15-21. PubMed ID: 22093595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breath ethane in dialysis patients and control subjects.
    Handelman GJ; Rosales LM; Barbato D; Luscher J; Adhikarla R; Nicolosi RJ; Finkelstein FO; Ronco C; Kaysen GA; Hoenich NA; Levin NW
    Free Radic Biol Med; 2003 Jul; 35(1):17-23. PubMed ID: 12826252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of low- and high-flux dialyzers on oxidative stress and insulin resistance.
    Chu PL; Chiu YL; Lin JW; Chen SI; Wu KD
    Blood Purif; 2008; 26(2):213-20. PubMed ID: 18285698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daily variation in death in patients treated by long-term dialysis: comparison of in-center hemodialysis to peritoneal and home hemodialysis.
    Krishnasamy R; Badve SV; Hawley CM; McDonald SP; Boudville N; Brown FG; Polkinghorne KR; Bannister KM; Wiggins KJ; Clayton P; Johnson DW
    Am J Kidney Dis; 2013 Jan; 61(1):96-103. PubMed ID: 22901771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renal replacement therapy by hemodialysis: an overview].
    Jacobs C
    Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of uremic retention products by hemodialysis is coupled with indiscriminate loss of vital metabolites.
    Zhang ZH; Mao JR; Chen H; Su W; Zhang Y; Zhang L; Chen DQ; Zhao YY; Vaziri ND
    Clin Biochem; 2017 Dec; 50(18):1078-1086. PubMed ID: 28928007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exhaled breath volatile organic and inorganic compound composition in end-stage renal disease.
    Schönermarck U; Dengler C; Gmeinwieser A; Praun S; Schelling G; Fischereder M; Boulesteix AL; Dolch ME
    Clin Nephrol; 2016 Sep; 86(9):132-40. PubMed ID: 27443565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breath analysis of ammonia, volatile organic compounds and deuterated water vapor in chronic kidney disease and during dialysis.
    Davies SJ; Španěl P; Smith D
    Bioanalysis; 2014 Mar; 6(6):843-57. PubMed ID: 24702114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphate removal with several thrice-weekly dialysis methods in overweight hemodialysis patients.
    Tonelli M; Wang W; Hemmelgarn B; Lloyd A; Manns B;
    Am J Kidney Dis; 2009 Dec; 54(6):1108-15. PubMed ID: 19619920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood and breath profiles of volatile organic compounds in patients with end-stage renal disease.
    Mochalski P; King J; Haas M; Unterkofler K; Amann A; Mayer G
    BMC Nephrol; 2014 Mar; 15():43. PubMed ID: 24607025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
    Cavdar C; Temiz A; Yeniçerioğlu Y; Calişkan S; Celik A; Sifil A; Onvural B; Camsari T
    Scand J Urol Nephrol; 2003; 37(1):77-82. PubMed ID: 12745750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.